A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
Clinical trial NCT05877924 · RECRUITING
Trial details
- NCT number
- NCT05877924
- Sponsor
- NovaRock Biotherapeutics, Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2025-08-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.